banner
GSK-3 inhibitor 1-Azakenpaullone, Purity ≥98%
Inquiry

Cat. No.: X24-05-ZQ249

GSK-3 inhibitor 1-Azakenpaullone, Purity ≥98%

Synonym: 676596-65-9; 1-Azakenpaullone; Azakenpaullone; 1-AKP; 9-Bromo-7,12-dihydropyrido[3',2':2,3]azepino[4,5-b]indol-6(5H)-one; GSK-3 inhibitor

  • CAS Number: 676596-65-9
  • Compound CID: 6538897
img
Product Size
2 mg; 5 mg; 10 mg
Price
Datasheet
MSDS
Properties
Description
1-Azakenpaullone, soluble in DMSO and insoluble in ethanol and water, modulates various cellular processes, including glucose metabolism, inflammation, and cell proliferation, with potential applications in treating diseases like diabetes and neurodegenerative disorders. It targets GSK-3α and GSK-3β.
Molecular Weight
328.16
Molecular Formula
C15H10BrN3O
Targets
GSK-3α; GSK-3β
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 38 nM (Ki); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
1-Azakenpaullone can be used to investigate its role as a GSK-3β inhibitor in cancer and neurobiology research.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0